CEO of Mach One Corp. to Air in Live MN1 Interview

Mach One Corp. (PINKSHEETS: MNCN) will be featured in an exclusive Market News First interview April 26, 2007 at 11:15 AM CST. Chief Executive Officer Monte Tobin will talk with MN1 "Microcap Engine" host Steve Kanaval on www.mn1.com about the Company's place in the equine/bovine market through their subsidiary, VDx, Inc.

Even though Mach One Corp. faces competition from many companies, universities, and research institutions in the United States and abroad, VDx is truly the first and only company with the product to allow for 100% absorption of IgG in newborn animals. Their process is patented and licensed by the USDA.

During the interview Tobin will highlight the Company's recent news and how it has strategically positioned itself for progression in the competitive and growing marketplace.

To learn more about Mach One Corp. and its investment opportunities, log on to www.mn1.com on April 26, 2007 at 11:15 AM CST.

About Mach One Corp.

Through its wholly owned subsidiary VDx, Inc. (www.vetdx.biz), the company specializes in Immune or Gamma Globulin replacement (IgG) for the equine and bovine markets. VDx currently manufactures and distributes Immunogam(TM), a colostrums replacement, supplement and prophylactic, in sterile powder form, that can be administered orally or intravenously. VDx is also further developing a proprietary procedure to allow for large scale manufacturing of colostral replacement products for market along with an added ingredient for mastitis and Johnnes disease.

About MN1.com

Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live IPTV web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies' present condition and future plans.